New study examines the effect of weight-loss drugs on pregnant women
In recent years, drugs like Ozempic have become very popular worldwide and in Israel as well, primarily for the treatment of diabetes and for weight loss. Now, researchers are trying to understand the effects of these drugs on women who became pregnant while using them.
An international team of researchers compiled data from seven different studies, which together included more than 43,000 women with diabetes. The women in the study were exposed to drugs from the GLP-1 family, the group to which the drug Ozempic belongs, during their pregnancy.
The goal of the study was to examine whether there is a link between the use of these drugs and health risks to the fetus or the baby after birth. Six of the seven studies focused on examining exposure to the drug during the first trimester of pregnancy, which is a critical period for fetal development.
The topic concerns many doctors and patients in Israel, as the use of these drugs has become very common. The new information is expected to help doctors make more informed medical decisions for women of childbearing age who suffer from diabetes and require medication.
In conclusion, the study represents an important step in understanding the safety of new drugs during pregnancy. However, experts emphasize that data must continue to be monitored to ensure the health of both mothers and babies.